CVSA vs GHC
Covista Inc. and Graham Holdings Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CVSA | GHC |
|---|---|---|
| Revenue | $2.0B | $4.9B |
| Net income | $251.6M | $292.3M |
| Gross margin | 57.3% | — |
| Net margin | 12.9% | 6.2% |
| Return on equity | 17.5% | 6.5% |
| Diluted EPS | $7.04 | $66.47 |
| Dividend / share | — | $7.20 |
| Payout ratio | — | — |
| Free cash flow | $392.7M | $275.3M |
| Equity | $1.4B | $4.8B |
| Net debt / equity | 0.18× | 0.13× |
| Current ratio | 1.09× | 1.75× |
| Revenue CAGR 5y | 16.8% | 11.2% |
| Profit CAGR 5y | 29.1% | −0.5% |
GHC bills 2.5× the revenue of CVSA, and CVSA keeps more of each dollar of revenue as profit (12.9% against 6.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CVSA | GHC |
|---|---|---|
| FY2025 | $2.0B | $4.9B |
| FY2024 | $1.8B | $4.8B |
| FY2023 | $1.6B | $4.4B |
| FY2022 | $1.5B | $3.9B |
| FY2021 | $1.4B | $3.2B |
| FY2020 | $899.2M | $2.9B |
| FY2019 | $866.4M | $2.9B |
| FY2018 | $1.0B | $2.7B |
| FY2017 | $960.3M | $2.6B |
| FY2016 | $1.2B | $2.5B |
Net income by year
Bottom line
| Fiscal year | CVSA | GHC |
|---|---|---|
| FY2025 | $251.6M | $292.3M |
| FY2024 | $237.1M | $724.6M |
| FY2023 | $136.8M | $205.3M |
| FY2022 | $93.4M | $67.1M |
| FY2021 | $311.0M | $352.1M |
| FY2020 | $70.0M | $300.4M |
| FY2019 | $-85.3M | $327.9M |
| FY2018 | $95.2M | $271.2M |
| FY2017 | $33.8M | $302.0M |
| FY2016 | $122.3M | $168.6M |